We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
+10.13%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$53.9B
AUM Growth
-$21B
(-28%)
Cap. Flow
+$1.12B
Cap. Flow
% of AUM
2.08%
Top 10 Holdings %
Top 10 Hldgs %
31.63%
Holding
3,163
New
260
Increased
1,432
Reduced
926
Closed
418
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$395M |
| 2 |
State Street Real Estate Select Sector SPDR ETF
XLRE
|
+$171M |
| 3 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$160M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$147M |
| 5 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$105M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares National Muni Bond ETF
MUB
|
+$105M |
| 2 |
Vanguard Total Stock Market ETF
VTI
|
+$78.8M |
| 3 |
Vanguard Real Estate ETF
VNQ
|
+$68.3M |
| 4 |
Amazon
AMZN
|
+$39.8M |
| 5 |
PepsiCo
PEP
|
+$38.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.19% |
| 2 | Financials | 4.43% |
| 3 | Consumer Discretionary | 2.64% |
| 4 | Healthcare | 2.52% |
| 5 | Industrials | 1.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PSTX
2651
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $45.7K | ﹤0.01% |
13,600
| – | – |
|
2652
Genasys
GNSS
$75.6M
| $43.7K | ﹤0.01% |
21,550
| – | – |
|
|
CNF
2653
CNFinance Holdings
CNF
$40.3M
| $42.9K | ﹤0.01% |
1,932
| – | – |
|
2654
Petco
WOOF
$745M
| $42K | ﹤0.01% |
13,279
+13,179
| +13,179% | +$45.5K |
|
|
HIO
2655
Western Asset High Income Opportunity Fund
HIO
$335M
| $41.9K | ﹤0.01% |
10,844
| – | – |
|
2656
Opko Health
OPK
$921M
| $41.2K | ﹤0.01% |
27,266
-71,479
| -72% | -$103K |
|
2657
Galectin Therapeutics
GALT
$229M
| $40.2K | ﹤0.01% |
24,214
+4,000
| +20% | +$7.76K |
|
2658
AtaiBeckley Inc
ATAI
$2.66B
| $39.8K | ﹤0.01% |
28,218
+2,406
| +9% | +$2.99K |
|
|
GLDG
2659
GoldMining Inc
GLDG
$179M
| $39.4K | ﹤0.01% |
40,421
| – | – |
|
2660
PUT
Cincinnati Financial
CINF
$28.3B
| $39.4K | ﹤0.01% |
45,000
| – | – |
|
|
FSR
2661
DELISTED
Fisker Inc.
FSR
| $38.4K | ﹤0.01% |
21,919
-9,005
| -29% | -$31.9K |
|
2662
Cardiff Oncology
CRDF
$64.3M
| $37.7K | ﹤0.01% |
25,500
-33,251
| -57% | -$40.2K |
|
2663
Douglas Elliman
DOUG
$155M
| $37.1K | ﹤0.01% |
12,592
-322
| -2% | -$675 |
|
2664
BlackBerry
BB
$5.01B
| $37.1K | ﹤0.01% |
+10,488
| New | +$39.4K |
|
2665
Arbutus Biopharma
ABUS
$865M
| $36.4K | ﹤0.01% |
+14,566
| New | +$28.5K |
|
|
AMRN
2666
Amarin Corp
AMRN
$284M
| $36.3K | ﹤0.01% |
2,088
| – | – |
|
2667
KORU Medical Systems
KRMD
$176M
| $36K | ﹤0.01% |
14,667
| – | – |
|
2668
PUT
NVIDIA
NVDA
$5.01T
| $34.9K | ﹤0.01% |
192,000
-7,000
| -4% | -$324K |
|
|
KEEL
2669
Keel Infrastructure Corp
KEEL
$2.57B
| $33.4K | ﹤0.01% |
+11,477
| New | +$18.4K |
|
2670
Precigen
PGEN
$1.93B
| $33.1K | ﹤0.01% |
24,722
-204,920
| -89% | -$241K |
|
|
ME
2671
DELISTED
23andMe Holding Co
ME
| $32.9K | ﹤0.01% |
1,801
-484
| -21% | -$8.37K |
|
2672
SAB Biotherapeutics
SABS
$268M
| $32.7K | ﹤0.01% |
4,752
| – | – |
|
|
CIK
2673
Credit Suisse Asset Management Income Fund
CIK
$133M
| $32.2K | ﹤0.01% |
+10,276
| New | +$28.2K |
|
2674
Laird Superfood
LSF
$46.2M
| $30.4K | ﹤0.01% |
33,440
-2,485
| -7% | -$2.23K |
|
2675
PUT
CoinShares ETF Trust CoinShares Bitcoin Mining ETF
WGMI
$247M
| $29.3K | ﹤0.01% |
+15,000
| New | +$174K |
|
Similar funds
Creative Planning's Q4 2023 Portfolio in Review
As of Q4 2023, Creative Planning held 3,163 positions worth $53.9B, down 28% from $74.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Creative Planning's Q4 2023 filing shows 260 new, 1,432 increased, 926 reduced and 418 closed positions. Its largest new stake was Avantis Core Fixed Income ETF: 333,301 shares worth $13.9M. The largest sale was iShares National Muni Bond ETF, an estimated $105M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 5.2% a quarter earlier, followed by Financials and Consumer Discretionary.
- Creative Planning's largest Q4 2023 buy was Avantis Core Fixed Income ETF: 333,301 shares worth $13.9M.
- Creative Planning added most to Vanguard Total Bond Market in Q4 2023, an estimated $395M increase.
- Creative Planning's biggest Q4 2023 reduction was iShares National Muni Bond ETF, cutting an estimated $105M.
- Creative Planning fully exited iShares iBonds Dec 2023 Term Corporate ETF in Q4 2023, selling an estimated $9.03M.
- Creative Planning's ten largest holdings make up 32% of its $53.9B portfolio in Q4 2023.
- Creative Planning opened 260 new positions and closed 418 in Q4 2023.
- Creative Planning's portfolio value fell 28% quarter-over-quarter to $53.9B.
Based on Creative Planning's 13F filing for Q4 2023, filed 14 Feb 2024.